Table 1.
Chronic diseases and assigned ATC-codes and medication classes
| Chronic condition | ATC classification | Medication class |
|---|---|---|
| Acid related disorders |
A02 |
Antacids |
| Drugs for peptic ulcer and gastroesophageal reflux disease (GERD) | ||
| Other drugs for acid related disorders | ||
| Bone diseases (osteoporosis) |
M05 |
Drugs for treatment of bone diseases |
| Cancer |
L01 |
Antineoplastic agents |
| Cardiovascular diseases (incl. hypertension) |
B01AA, B01AC, |
Cardiac agents (excl. ACE inhibitors) |
| C01, C04A, |
Antihypertensives |
|
| C02, C07, |
Peripheral vasodilators |
|
| C08, C09 |
Beta blocking agents |
|
| Calcium channel blockers | ||
| Agents acting on the renin-angiotensin system | ||
| Vitamin K antagonists | ||
| |
Platelet aggregation inhibitors (excl. herparin) |
|
| Dementia |
N06D |
Anti-dementia drugs |
| Diabetes mellitus |
A10A, A10B, |
Insulins and analogues |
| A10X |
Blood glucose lowering drugs (excl. insulins) |
|
| Other drugs used in diabetes | ||
| Epilepsy |
N03 |
Antiepileptics |
| Glaucoma |
S01E |
Antiglaucoma preparations and miotics |
| Gout, Hyperuricemia |
M04 |
Antigout preparations |
| HIV |
J05AE, J05AG, |
Protease inhibitors |
| J05AR |
Non-nucleoside reverse transcriptase inhibitorsAntivirals for treatment of HIV infections, combinations |
|
| Hyperlipidemia |
C10 |
Lipid modifying agents |
| Intestinal inflammatory diseases |
A07EA, A07EC |
Corticosteroids acting locallyAminosalicylic acid and similar agents |
| Iron deficiency anemia |
B03AA, B03AB, |
Iron bivalent, oral prepartations |
| Iron trivalent, oral preparations | ||
| B03AC |
Iron trivalent, parenteral preparations |
|
| Migraines |
N02C |
Antimigraine preparations |
| Pain |
N02A, N02B |
Opioids |
| Other analgesics | ||
| Parkinson’s disease |
N04 |
Anti-parkinson drugs |
| Psycholgical disorders (sleep disorder, depression) |
N05B, N05C, |
Anxiolytics |
| N06A |
Hypnotics and sedativesAntidepressants |
|
| Psychoses |
N05A |
Antipsychotics |
| Respiratory illness (asthma, COPD) |
R03 |
Drugs for obstructive airway diseases |
| Rheumatologic conditions |
M01, M02 |
Antiflammatory and antirheumatic products |
| L04AA, L04AB |
Topical products for joint and muscular pain |
|
| Selective immunosuppressants | ||
| TNF-alpha inhibitors | ||
| Thyroid disorders |
H03 |
Drugs for thyroid therapy |
| Tuberculosis | J04A | Drugs for treatment of tuberculosis |